| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 1130 |
| 1 | NAPROXEN SODIUM | 1118 |
| 2 | DICLOFENAC SODIUM | 1104 |
| 3 | LEFLUNOMIDE | 1103 |
| 4 | SECUKINUMAB | 1091 |
| 5 | ERENUMAB-AOOE | 1086 |
| 6 | CETIRIZINE HYDROCHLORIDE | 1072 |
| 7 | DICLOFENAC | 1072 |
| 8 | ADALIMUMAB-ADAZ | 1055 |
| 9 | CETIRIZINE | 1038 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | 12%AZELAIC ACID | 95 | 0.1132 |
| 1 | HYDROCORTISONE BUTYRATE | 203 | 0.1027 |
| 2 | AZELAIC ACID | 95 | 0.0962 |
| 3 | LEVOMILNACIPRAN HYDROCHLORIDE | 167 | 0.0866 |
| 4 | NICOTINAMIDE | 213 | 0.0834 |
| 5 | ADRENAL SUPPORT | 2 | 0.0800 |
| 6 | GOLD | 433 | 0.0746 |
| 7 | BOTULINUM TOXIN TYPE A | 895 | 0.0700 |
| 8 | PSEUDOEPHEDRINE HCL | 737 | 0.0673 |
| 9 | GOLIMUMAB | 780 | 0.0619 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nonsteroidal Anti-inflammatory Drug [EPC] | 1635 |
| 1 | Corticosteroid [EPC] | 1488 |
| 2 | Tumor Necrosis Factor Blocker [EPC] | 1323 |
| 3 | Antirheumatic Agent [EPC] | 1103 |
| 4 | Vitamin C [EPC] | 1101 |
| 5 | CD20-directed Cytolytic Antibody [EPC] | 1096 |
| 6 | Interleukin-17A Antagonist [EPC] | 1092 |
| 7 | Anti-epileptic Agent [EPC] | 1054 |
| 8 | Interleukin-6 Receptor Antagonist [EPC] | 1054 |
| 9 | Acetylcholine Release Inhibitor [EPC] | 1052 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 813 | 1.1817 |
| 1 | Provitamin D2 Compound [EPC] | 907 | 0.0305 |
| 2 | Interleukin-17A Antagonist [EPC] | 1092 | 0.0293 |
| 3 | beta3-Adrenergic Agonist [EPC] | 825 | 0.0173 |
| 4 | Endoglycosidase [EPC] | 28 | 0.0151 |
| 5 | Antiseptic [EPC] | 62 | 0.0142 |
| 6 | Acetylcholine Release Inhibitor [EPC] | 1052 | 0.0106 |
| 7 | Antirheumatic Agent [EPC] | 1103 | 0.0104 |
| 8 | Human C1 Esterase Inhibitor [EPC] | 40 | 0.0103 |
| 9 | Aminosalicylate [EPC] | 961 | 0.0095 |